Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,486 | -5,886 | -4,177 | -2,675 | -6,350 |
| Depreciation Amortization | 50 | 41 | 5 | 2 | 21 |
| Other Working Capital | -441 | -342 | -349 | 110 | 113 |
| Other Operating Activity | 1,034 | 1,313 | 808 | 336 | 2,084 |
| Operating Cash Flow | $-5,843 | $-4,875 | $-3,713 | $-2,227 | $-4,132 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -53 | -49 | N/A | N/A | -94 |
| Investing Cash Flow | $-53 | $-49 | $N/A | $N/A | $-94 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,150 |
| Debt Repayment | -28 | -28 | -28 | -44 | N/A |
| Common Stock Issued | 15 | 5 | 5 | 1 | 8,360 |
| Other Financing Activity | -173 | -131 | -88 | 0 | -183 |
| Financing Cash Flow | $-186 | $-154 | $-112 | $-43 | $13,326 |
| Beginning Cash Position | 10,117 | 10,117 | 10,117 | 10,117 | 1,016 |
| End Cash Position | 4,034 | 5,039 | 6,292 | 7,847 | 10,117 |
| Net Cash Flow | $-6,083 | $-5,078 | $-3,824 | $-2,270 | $9,101 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,843 | -4,875 | -3,713 | -2,227 | -4,132 |
| Capital Expenditure | -53 | -49 | N/A | N/A | -94 |
| Free Cash Flow | -5,896 | -4,924 | -3,713 | -2,227 | -4,226 |